SUZHOU, China, June 18, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Biosafety Testing Center in Suzhou has successfully passed a Good Manufacturing Practice (GMP) inspection by...
Hence then, the article about wuxi biologics suzhou biosafety testing center received fourth ema gmp certification enabling 19 commercial products for the european market was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market )
Also on site :
- JCPenney’s ‘Delicate’ Pink Sapphire Pendant Necklace Is a ‘Beautiful’ Holiday Gift, Now 79% Off
- Southeast Asia shouldn’t copy the U.S. healthcare model, says Walgreens Boots Alliance’s APAC head: ‘It saves your life, but it’s not very healthy’
- Taiwan Audience Study Highlights Cross-Platform IP Opportunities as AI Raises New Risks for Content Industry